BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seok Y, Yang HC, Kim TJ, Lee KW, Kim K, Jheon S, Cho S. Frequency of lymph node metastasis according to the size of tumors in resected pulmonary adenocarcinoma with a size of 30 mm or smaller. J Thorac Oncol 2014;9:818-24. [PMID: 24787961 DOI: 10.1097/JTO.0000000000000169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Liao Y, Liu P, Du Q, Liang Y, Ooi S, Qin S, He S, Yao S, Wang W. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics 2020;10:6561-80. [PMID: 32550890 DOI: 10.7150/thno.44868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
2 Haque W, Singh A, Park HS, Teh BS, Butler EB, Zeng M, Lin SH, Welsh JW, Chang JY, Verma V. Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer. Acta Oncol 2021;:1-6. [PMID: 34913815 DOI: 10.1080/0284186X.2021.2012253] [Reference Citation Analysis]
3 Grbic K, Mujakovic A, Lepara O, Lepara Z, Begic E, Krupic F. Biomarker Potential of Preoperative Tumor Size in Determination of the Lymphovascular Invasion in Squamous Cell Lung Cancer and Lung Adenocarcinoma. Int J Appl Basic Med Res 2021;11:95-9. [PMID: 33912429 DOI: 10.4103/ijabmr.IJABMR_500_20] [Reference Citation Analysis]
4 Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J, Chen R, Lin T. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest 2020;130:404-21. [PMID: 31593555 DOI: 10.1172/JCI130892] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 34.0] [Reference Citation Analysis]
5 Ding N, Mao Y, Gao S, Xue Q, Wang D, Zhao J, Gao Y, Huang J, Shao K, Feng F, Zhao Y, Yuan L. Predictors of lymph node metastasis and possible selective lymph node dissection in clinical stage IA non-small cell lung cancer. J Thorac Dis 2018;10:4061-8. [PMID: 30174849 DOI: 10.21037/jtd.2018.06.129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
6 Zhang R, Zhang X, Huang Z, Wang F, Lin Y, Wen Y, Liu L, Li J, Liu X, Xie W, Huang M, Wang G, Yang L, Zhao D, Yu X, Xi K, Wang W, Cai L, Zhang L. Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer. Transl Lung Cancer Res 2020;9:722-30. [PMID: 32676334 DOI: 10.21037/tlcr-20-593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chua GWY, Chua KLM. Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non-small cell lung cancer? An in-depth look at patient characteristics on both sides of the debate. Thorac Cancer 2019;10:1857-67. [PMID: 31389163 DOI: 10.1111/1759-7714.13160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Yang CJ, Gulack BC, Gu L, Speicher PJ, Wang X, Harpole DH, Onaitis MW, D'amico TA, Berry MF, Hartwig MG. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2015;150:1484-93. [DOI: 10.1016/j.jtcvs.2015.06.062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
9 Verma V, Simone CB 2nd. Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer. Transl Lung Cancer Res 2019;8:70-7. [PMID: 30788236 DOI: 10.21037/tlcr.2018.06.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]